During the past decade, OptumCare Cancer Care at Oakey conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 16 clinical trials were completed, i.e. on average, 59.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 16 clinical trials were completed. i.e. 320% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OptumCare Cancer Care at Oakey" #1 sponsor was "SWOG Cancer Research Network" with 12 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "NRG Oncology" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OptumCare Cancer Care at Oakey" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "OptumCare Cancer Care at Oakey" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials) and "Stage IVB Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "OptumCare Cancer Care at Oakey" in a lesser frequency.

Most popular intervention types in "OptumCare Cancer Care at Oakey" are "Drug" (24 trials), "Other" (22 trials), "Biological" (8 trials), "Procedure" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (6 trials), "Placebo" (5 trials), "Questionnaire Administration" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "OptumCare Cancer Care at Oakey" are 27 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "OptumCare Cancer Care at Oakey". undefined are not yet recruiting, 3 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in OptumCare Cancer Care at Oakey, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in OptumCare Cancer Care at Oakey, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".